Nyxoah Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Nyxoah's earnings have been declining at an average annual rate of -39.1%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 60.6% per year.
Información clave
-39.1%
Tasa de crecimiento de los beneficios
-24.1%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 12.3% |
| Tasa de crecimiento de los ingresos | 60.6% |
| Rentabilidad financiera | -36.2% |
| Margen neto | -908.5% |
| Próxima actualización de resultados | 06 Nov 2024 |
Actualizaciones de resultados anteriores recientes
Desglose de ingresos y gastos
Cómo gana y gasta dinero Nyxoah. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 5 | -44 | 22 | 29 |
| 31 Mar 24 | 5 | -43 | 22 | 28 |
| 31 Dec 23 | 4 | -43 | 22 | 27 |
| 30 Sep 23 | 4 | -46 | 22 | 24 |
| 30 Jun 23 | 3 | -44 | 22 | 22 |
| 31 Mar 23 | 3 | -36 | 20 | 18 |
| 31 Dec 22 | 3 | -31 | 19 | 16 |
| 30 Sep 22 | 2 | -24 | 17 | 15 |
| 30 Jun 22 | 2 | -27 | 17 | 14 |
| 31 Mar 22 | 1 | -29 | 17 | 14 |
| 31 Dec 21 | 1 | -28 | 15 | 12 |
| 30 Sep 21 | 1 | -25 | 13 | 10 |
| 30 Jun 21 | 0 | -21 | 12 | 8 |
| 31 Mar 21 | 0 | -16 | 9 | 5 |
| 31 Dec 20 | 0 | -12 | 9 | 2 |
| 30 Sep 20 | 0 | -8 | 7 | 3 |
| 30 Jun 20 | 0 | -5 | 6 | 2 |
| 31 Mar 20 | 0 | -4 | 5 | 2 |
| 31 Dec 19 | 0 | -4 | 4 | 2 |
| 31 Dec 18 | 0 | -9 | 3 | 4 |
Ingresos de calidad: NYXH is currently unprofitable.
Margen de beneficios creciente: NYXH is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NYXH is unprofitable, and losses have increased over the past 5 years at a rate of 39.1% per year.
Acelerando crecimiento: Unable to compare NYXH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: NYXH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Rentabilidad financiera
Alta ROE: NYXH has a negative Return on Equity (-36.24%), as it is currently unprofitable.